bearish
A-H Premium Weekly: Healthcare Led Premium Decline
281 Views10 Apr 2022 12:01
A-H premium declined by 3.0ppt last week, led by consumer staple, consumer discretionary and heathcare. We highlight names including Shenzhen HepaLink, Shandong Xinhua Pharm, and Shanghai Haohai.
SUMMARY
(Sign Up to Access)Get started on the Smartkarma Research Network with a complimentary Preview Pass to:
- Unlock all research summaries
- Follow top, independent analysts
- Receive personalised alerts and emails
- Access Briefings, Analytics, and Events
Upgrade anytime to our paid plans for full-length research, real-time analyst discussions, and more.
Join a thriving community of 45,000+ investors, including the top global asset managers managing over $13trn in assets.
or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 6-minute read)
Discussions
(Paid Plans Only)
- A-H Premium Weekly: Asymchem Lab, China Comm Construction02 May 2022
- A-H Premium Weekly: China Southern, Shanghai Junshi, Shanghai Haohai, Shanghai Fudan24 Apr 2022
- A-H Premium Weekly: Real Estate, Industrials, Utilities Led the Decline17 Apr 2022
- A-H Premium Weekly: Healthcare Led Premium Decline10 Apr 2022
- A-H Premium Weekly: Real Estate at 52 Week High03 Apr 2022
- A-H Premium Weekly: Shanghai Pharma, China Eastern Air, Huaneng Power, Shenzhen Hepalink27 Mar 2022
x